Bioactive Compound Database

Traditional drug discovery requires the de novo identification and validation of new chemical entities, a process that is notoriously time-consuming and capital-intensive. As regulatory requirements for safety evaluations become more stringent, the cost of developing new drugs continues to escalate. Consequently, strategies to compress research timelines and reduce expenditures have become paramount. Modern pharmaceutical research has yielded a vast library of bioactively validated compounds, many of which have successfully reached the market. These bioactive compounds possess significantly higher druggability potential than most generic drug-like molecules. However, many remain under-explored for broader functional applications. Leveraging these compounds as starting points for drug discovery exponentially increases the probability of identifying high-quality hits.

Drug Repurposing ("Old Drugs, New Uses")

Drug repurposing ("old drugs, new uses") is currently a high-profile R&D strategy, which involves applying existing drugs to new indications, focusing on marketed drugs or clinical-stage drugs. Since there is already considerable understanding of the tolerance, human delivery characteristics, and kinetics of these drugs, they can be used more effectively and safely. More importantly, compared to de novo drug R&D, the time and economic costs required for drug repurposing are relatively much smaller. With the development of big data analysis, computer models, and large-scale screening systems, drug repurposing will become even more attractive.

AnyMol Active Compound Database

AnyMol has systematically organized and summarized bioactive compound libraries from major global suppliers. Our collection includes over 130,000 compounds with documented bioactivity and 159 specialized bioactive libraries, such as Approved Drug Libraries and Clinical-stage Drug Libraries.

These resources provide critical data for SAR (Structure-Activity Relationship) studies, drug repurposing, and screening model validation. The vast majority of compounds in our bioactive database are available in stock, ensuring reliable support for subsequent experimental validation. These bioactive compounds serve a variety of research purposes:

High-Throughput Screening (HTS)

Provides collections of tens of thousands of bioactive compounds, fully meeting the demands of large-scale screening.

Drug Repurposing

Features clear activity and target information—especially within the approved and clinical libraries—making them essential tools for "old drugs, new uses" strategies.

Signaling Pathway Research

Libraries with well-defined targets can be utilized as modulators for specific signaling pathways, such as our dedicated GPCR libraries.

Cell Induction and Differentiation

Offers small molecules for cell induction. Through the action of single or combined small molecules, various somatic cells can be induced into induced pluripotent stem cells (iPSCs), neural progenitor cells, cardiomyocytes, and more.

Submit Your Request

Please complete the technical requirement form below, and our team will get back to you as soon as possible!

Loading ~